- Home
- ADVM vs CFSB Comparison
ADVM vs CFSB Comparison
Compare ADVM & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- CFSB
- Stock Information
- Founded
- ADVM 2006
- CFSB 1889
- Country
- ADVM United States
- CFSB United States
- Employees
- ADVM N/A
- CFSB N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- CFSB Major Banks
- Sector
- ADVM Health Care
- CFSB Finance
- Exchange
- ADVM Nasdaq
- CFSB Nasdaq
- Market Cap
- ADVM 47.4M
- CFSB 51.6M
- IPO Year
- ADVM 2014
- CFSB N/A
- Fundamental
- Price
- ADVM $2.39
- CFSB $13.75
- Analyst Decision
- ADVM Strong Buy
- CFSB
- Analyst Count
- ADVM 5
- CFSB 0
- Target Price
- ADVM $23.80
- CFSB N/A
- AVG Volume (30 Days)
- ADVM 338.5K
- CFSB 7.4K
- Earning Date
- ADVM 08-11-2025
- CFSB 07-29-2025
- Dividend Yield
- ADVM N/A
- CFSB N/A
- EPS Growth
- ADVM N/A
- CFSB N/A
- EPS
- ADVM N/A
- CFSB N/A
- Revenue
- ADVM $1,000,000.00
- CFSB $7,484,000.00
- Revenue This Year
- ADVM N/A
- CFSB N/A
- Revenue Next Year
- ADVM $18.82
- CFSB N/A
- P/E Ratio
- ADVM N/A
- CFSB N/A
- Revenue Growth
- ADVM N/A
- CFSB N/A
- 52 Week Low
- ADVM $1.78
- CFSB $6.34
- 52 Week High
- ADVM $10.14
- CFSB $13.78
- Technical
- Relative Strength Index (RSI)
- ADVM 44.19
- CFSB 88.96
- Support Level
- ADVM $2.11
- CFSB $13.68
- Resistance Level
- ADVM $2.60
- CFSB $13.70
- Average True Range (ATR)
- ADVM 0.22
- CFSB 0.01
- MACD
- ADVM -0.00
- CFSB -0.18
- Stochastic Oscillator
- ADVM 33.33
- CFSB 90.91
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.